Marona P - Search Results

1

MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs.

Gorka J, Marona P, Kwapisz O, Waligórska A, Pospiech E, Dobrucki JW, Rys J, Jura J, Miekus K. Gorka J, et al. Among authors: marona p. Oncogene. 2021 Dec;40(50):6720-6735. doi: 10.1038/s41388-021-02062-3. Epub 2021 Oct 16. Oncogene. 2021. PMID: 34657130 Free PMC article.

2

MCPIP1 contributes to clear cell renal cell carcinomas development.

Ligeza J, Marona P, Gach N, Lipert B, Miekus K, Wilk W, Jaszczynski J, Stelmach A, Loboda A, Dulak J, Branicki W, Rys J, Jura J. Ligeza J, et al. Among authors: marona p. Angiogenesis. 2017 Aug;20(3):325-340. doi: 10.1007/s10456-017-9540-2. Epub 2017 Feb 14. Angiogenesis. 2017. PMID: 28197812 Free PMC article.

3

MCPIP1 Downregulation in Clear Cell Renal Cell Carcinoma Promotes Vascularization and Metastatic Progression.

Marona P, Górka J, Mazurek Z, Wilk W, Rys J, Majka M, Jura J, Miekus K. Marona P, et al. Cancer Res. 2017 Sep 15;77(18):4905-4920. doi: 10.1158/0008-5472.CAN-16-3190. Epub 2017 Jul 17. Cancer Res. 2017. PMID: 28716897

4

Fatty Acids and a High-Fat Diet Induce Epithelial-Mesenchymal Transition by Activating TGFβ and β-Catenin in Liver Cells.

Kwapisz O, Górka J, Korlatowicz A, Kotlinowski J, Waligórska A, Marona P, Pydyn N, Dobrucki JW, Jura J, Miekus K. Kwapisz O, et al. Among authors: marona p. Int J Mol Sci. 2021 Jan 28;22(3):1272. doi: 10.3390/ijms22031272. Int J Mol Sci. 2021. PMID: 33525359 Free PMC article.

5

Resistance to tyrosine kinase inhibitors promotes renal cancer progression through MCPIP1 tumor-suppressor downregulation and c-Met activation.

Marona P, Górka J, Kwapisz O, Jura J, Rys J, Hoffman RM, Miekus K. Marona P, et al. Cell Death Dis. 2022 Sep 22;13(9):814. doi: 10.1038/s41419-022-05251-4. Cell Death Dis. 2022. PMID: 36138026 Free PMC article.

6

The anti-inflammatory protein MCPIP1 inhibits the development of ccRCC by maintaining high levels of tumour suppressors.

Gorka J, Marona P, Kwapisz O, Rys J, Jura J, Miekus K. Gorka J, et al. Among authors: marona p. Eur J Pharmacol. 2020 Dec 5;888:173591. doi: 10.1016/j.ejphar.2020.173591. Epub 2020 Sep 21. Eur J Pharmacol. 2020. PMID: 32971087

7

MCPIP1 regulates focal adhesion kinase and Rho GTPase-dependent migration in clear cell renal cell carcinoma.

Gorka J, Marona P, Kwapisz O, Rys J, Jura J, Miekus K. Gorka J, et al. Among authors: marona p. Eur J Pharmacol. 2022 May 5;922:174804. doi: 10.1016/j.ejphar.2022.174804. Epub 2022 Mar 4. Eur J Pharmacol. 2022. PMID: 35257717 Free article.

8

C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas.

Marona P, Górka J, Kotlinowski J, Majka M, Jura J, Miekus K. Marona P, et al. Cells. 2019 Mar 22;8(3):272. doi: 10.3390/cells8030272. Cells. 2019. PMID: 30909397 Free PMC article. Review.

9

Heme Oxygenase-1 Controls an HDAC4-miR-206 Pathway of Oxidative Stress in Rhabdomyosarcoma.

Ciesla M, Marona P, Kozakowska M, Jez M, Seczynska M, Loboda A, Bukowska-Strakova K, Szade A, Walawender M, Kusior M, Stepniewski J, Szade K, Krist B, Yagensky O, Urbanik A, Kazanowska B, Dulak J, Jozkowicz A. Ciesla M, et al. Among authors: marona p. Cancer Res. 2016 Oct 1;76(19):5707-5718. doi: 10.1158/0008-5472.CAN-15-1883. Epub 2016 Aug 3. Cancer Res. 2016. PMID: 27488535

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters